S&P 500   4,535.10 (-0.02%)
DOW   35,560.44 (-0.14%)
QQQ   374.42 (-0.15%)
AAPL   149.47 (+0.14%)
MSFT   307.48 (+0.02%)
FB   339.17 (-0.47%)
GOOGL   2,824.86 (-0.37%)
TSLA   874.99 (+1.06%)
AMZN   3,413.62 (-0.04%)
NVDA   222.38 (+0.61%)
BABA   179.23 (+1.16%)
NIO   40.02 (+0.60%)
CGC   14.41 (+2.13%)
GE   106.08 (+0.08%)
AMD   117.60 (+1.04%)
MU   68.24 (-0.04%)
T   26.13 (+0.85%)
F   16.45 (+2.56%)
ACB   7.70 (+0.52%)
DIS   172.16 (+0.94%)
PFE   42.74 (-0.14%)
BA   217.38 (+0.56%)
AMC   41.19 (+0.76%)
S&P 500   4,535.10 (-0.02%)
DOW   35,560.44 (-0.14%)
QQQ   374.42 (-0.15%)
AAPL   149.47 (+0.14%)
MSFT   307.48 (+0.02%)
FB   339.17 (-0.47%)
GOOGL   2,824.86 (-0.37%)
TSLA   874.99 (+1.06%)
AMZN   3,413.62 (-0.04%)
NVDA   222.38 (+0.61%)
BABA   179.23 (+1.16%)
NIO   40.02 (+0.60%)
CGC   14.41 (+2.13%)
GE   106.08 (+0.08%)
AMD   117.60 (+1.04%)
MU   68.24 (-0.04%)
T   26.13 (+0.85%)
F   16.45 (+2.56%)
ACB   7.70 (+0.52%)
DIS   172.16 (+0.94%)
PFE   42.74 (-0.14%)
BA   217.38 (+0.56%)
AMC   41.19 (+0.76%)
S&P 500   4,535.10 (-0.02%)
DOW   35,560.44 (-0.14%)
QQQ   374.42 (-0.15%)
AAPL   149.47 (+0.14%)
MSFT   307.48 (+0.02%)
FB   339.17 (-0.47%)
GOOGL   2,824.86 (-0.37%)
TSLA   874.99 (+1.06%)
AMZN   3,413.62 (-0.04%)
NVDA   222.38 (+0.61%)
BABA   179.23 (+1.16%)
NIO   40.02 (+0.60%)
CGC   14.41 (+2.13%)
GE   106.08 (+0.08%)
AMD   117.60 (+1.04%)
MU   68.24 (-0.04%)
T   26.13 (+0.85%)
F   16.45 (+2.56%)
ACB   7.70 (+0.52%)
DIS   172.16 (+0.94%)
PFE   42.74 (-0.14%)
BA   217.38 (+0.56%)
AMC   41.19 (+0.76%)
S&P 500   4,535.10 (-0.02%)
DOW   35,560.44 (-0.14%)
QQQ   374.42 (-0.15%)
AAPL   149.47 (+0.14%)
MSFT   307.48 (+0.02%)
FB   339.17 (-0.47%)
GOOGL   2,824.86 (-0.37%)
TSLA   874.99 (+1.06%)
AMZN   3,413.62 (-0.04%)
NVDA   222.38 (+0.61%)
BABA   179.23 (+1.16%)
NIO   40.02 (+0.60%)
CGC   14.41 (+2.13%)
GE   106.08 (+0.08%)
AMD   117.60 (+1.04%)
MU   68.24 (-0.04%)
T   26.13 (+0.85%)
F   16.45 (+2.56%)
ACB   7.70 (+0.52%)
DIS   172.16 (+0.94%)
PFE   42.74 (-0.14%)
BA   217.38 (+0.56%)
AMC   41.19 (+0.76%)
CNSX:BAMM

BooksAMillion Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume20,889 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive BAMM News and Ratings via Email

Sign-up to receive the latest news and ratings for BooksAMillion and its competitors with MarketBeat's FREE daily newsletter.


About BooksAMillion

Body and Mind Inc. cultivates, produces, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, and Ohio. The company offers packaged and grinded flower buds; concentrates; disposable pen vaporizers; distillate oil cartridges; and distillate infused edible products. It produces and sells cannabis flowers, oil extracts, and edibles under the Body and Mind brand name. The company also operates ShowGrow San Diego dispensary; and manages ShowGrow Long Beach dispensary. In addition, it is involved in the production of marijuana extract products, such as distillate oils, ice waxes, dry sifts, shatters, edibles, and topicals. The company was formerly known as Deploy Technologies Inc. and changed its name to Body and Mind Inc. in November 2017. Body and Mind Inc. was founded in 1998 and is headquartered in Vancouver, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












BooksAMillion (CNSX:BAMM) Frequently Asked Questions

What stocks does MarketBeat like better than BooksAMillion?

Wall Street analysts have given BooksAMillion a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BooksAMillion wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are BooksAMillion's key executives?

BooksAMillion's management team includes the following people:
  • Mr. Michael Mills, Pres, CEO & Director (Age 51, Pay $219.62k)
  • Mr. Dong Hyun Shim B.B.A., CA, CPA, (Illinois), CFO & Director (Age 37, Pay $123.23k)
  • Mr. Stephen August Hoffman, COO & Director (Age 56, Pay $180k)
  • Mr. Darren Tindale, Corp. Sec. (Age 48, Pay $90k)
  • Mr. Harjit S. Grewal, VP of Corp. Devel. (Age 46)

What other stocks do shareholders of BooksAMillion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BooksAMillion investors own include Cresco Labs (CRLBF), Curaleaf (CURLF), KushCo (KSHB), Acreage (ACRGF), Aldeyra Therapeutics (ALDX), Amex Exploration (AMX), Better Plant Sciences (BOSQF), Cronos Group (CRON), Cardiol Therapeutics (CRTPF) and CV Sciences (CVSI).

What is BooksAMillion's stock symbol?

BooksAMillion trades on the CNSX under the ticker symbol "BAMM."

How do I buy shares of BooksAMillion?

Shares of BAMM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How many employees does BooksAMillion have?

BooksAMillion employs 101 workers across the globe.

What is BooksAMillion's official website?

The official website for BooksAMillion is www.bamcannabis.com.

How can I contact BooksAMillion?

The company can be reached via phone at 604-376-3567.


This page was last updated on 10/21/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.